Skip to content

Intervention for Fear of Progression in Mid-to-Late Stage Lung Cancer Patients: An Application of Hope Theory?

Intervention for Fear of Progression in Mid-to-Late Stage Lung Cancer Patients: An Application of Hope Theory?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112663
Enrollment
Unknown
Registered
2025-11-18
Start date
2025-11-18
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fear of Progression (FoP) in Advanced Lung Cancer Patients

Interventions

Experimental Group:A Hope Theory-Based Intervention Protocol for Managing Fear of Progression in Patients with Advanced Lung Cancer

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age >=18 years old and <-75 years old; 2. Clinically confirmed as primary lung cancer, and the clinical stage is between stage III and stage IV; 3. The condition is relatively stable and can cooperate to complete the intervention and assessment. 4. The score of the patient's Fear of Disease Progression Scale (FoP-Q-SF) is greater than or equal to 34 points; 5. The patient's Herth Hope Scale score is less than 36 points; 6. Patients who are currently treated with chemotherapy combined with immunotherapy and have a treatment interval of 21 days; 7. Possess a smart phone with an Internet connection and install the wechat program, and be capable of independently or with the assistance of their primary caregiver to complete basic wechat operations (including health information inquiry, online version number: V3.0 version date: September 25, 2025 4 communication, assignment submission and video learning, etc.); 8. Those who live with family members or have regular care; 9. No previous history of mental or psychological illness.

Exclusion criteria

Exclusion criteria: 1. Those who are currently participating in other research or have previously received psychological treatment; 2. Patients with other malignant tumors or acute and critical conditions; 3. Patients who are pregnant or breastfeeding; 4. Those with severe pleural effusion, uncontrolled chest tightness and shortness of breath, a recent history of pulmonary embolism, or those deemed unsuitable for breathing training by a doctor.

Design outcomes

Primary

MeasureTime frame
Fear of progression;

Secondary

MeasureTime frame
Quality of life;Carcinoembryonic antigen levels;Levels of family resilience;Level of hope;

Countries

China

Contacts

Public ContactYin Xiangyi

The First Affiliated Hospital of Army Medical University

1013793966@qq.com+86 17623613887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026